Mizuho Medy Co (TSE:4595) Ending Cash Position: 円0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4595 Mizuho Medy Co Ltd TSE:4595
80 GF Score
Price 円1,741.00
GF Value 円1,351.89
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Mizuho Medy Co Ending Cash Position?

Mizuho Medy Co TSE:4595 +0.64% 80 Ending Cash Position is 円0 Mil as of Jun. 2026. GuruFocus rates TSE:4595 with a GF Score™ of 80/100 and a GF Value™ of 円1,351.89 (Modestly Overvalued). The stock has 3 warning signs investors should review.

Mizuho Medy Co's Ending Cash Position for the quarter that ended in Jun. 2026 was 円0 Mil.

Mizuho Medy Co's annual Ending Cash Position increased from Dec. 2023 (円8,716 Mil) to Dec. 2024 (円9,664 Mil) but then declined from Dec. 2024 (円9,664 Mil) to Dec. 2025 (円2,259 Mil).

Mizuho Medy Co Ending Cash Position Related Terms

Mizuho Medy Co Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Mizuho Medy Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mizuho Medy Co Ending Cash Position Chart

Mizuho Medy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,326.56 7,375.15 8,716.00 9,664.00 2,259.00

Mizuho Medy Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4595
80GF Score
Mizuho Medy Co Ltd TSE:4595
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mizuho Medy Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Mizuho Medy Co's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=9664+-7405
=2,259

Mizuho Medy Co's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of 円0 Mil mean?
Mizuho Medy Co (TSE:4595) has a Ending Cash Position of 円0 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Mizuho Medy Co and its competitors.
Is Mizuho Medy Co's Ending Cash Position too high?
Mizuho Medy Co's current Ending Cash Position is 円0 Mil. Overall, Mizuho Medy Co has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mizuho Medy Co's Ending Cash Position compare to ZTS?
Mizuho Medy Co's Ending Cash Position of 円0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Mizuho Medy Co and its competitors. Mizuho Medy Co's current Ending Cash Position is 円0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mizuho Medy Co stock overvalued right now?
Based on GuruFocus' analysis, Mizuho Medy Co (TSE:4595) is currently considered Modestly Overvalued. The stock's GF Value™ is 円1,351.89, compared to a current price of 円1,741.00 — trading 28.8% above its estimated fair value. The current Ending Cash Position is 円0 Mil. Mizuho Medy Co's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Mizuho Medy Co (TSE:4595), the current Ending Cash Position is 円0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mizuho Medy Co (TSE:4595) Overvalued in 2026?

Based on GuruFocus' analysis, Mizuho Medy Co stock appears to be overvalued. The current stock price of 円1,741.00 is trading 28.8% above its estimated GF Value™ of 円1,351.89. GuruFocus considers Mizuho Medy Co to be Modestly Overvalued.

Key valuation signals for TSE:4595:

  • Ending Cash Position: 円0 Mil
  • GF Value™: 円1,351.89 vs. price of 円1,741.00 (28.8% above fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the TSE:4595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mizuho Medy Co Business Description

Address 5-4 Fujinoki-machi, Saga Prefecture, Tosu, JPN, 841-0048
Mizuho Medy Co Ltd engages in research and development, manufacture, and distribution of in-vitro diagnostic products. The company provides immuno assay test products, such as influenza virus kits; Infectious diseases test kits; fecal occult blood test kits for detection of human hemoglobin and human transferrin in feces; and biochemical liquid stable reagents for professionals. It also offers HCG (midstream test), including a digital p-check test for OTC. It also offers fruit tree virus test drugs to agricultural testing places.
80GF Score

Get the complete analysis for TSE:4595

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,741.00
Price
円1,351.89
GF Value